Mesenchymal Precursor Cells (MPCs)

BIOLOGICAL3 trials

Sponsors

Mesoblast, Ltd.

Conditions

Diabetic NephropathyHeart FailureType 2 Diabetes

Phase 1

Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes

CompletedNCT01576328

Mesoblast, Ltd.Type 2 Diabetes

Start: 2012-04-30End: 2015-10-31Updated: 2020-06-02

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

CompletedNCT01843387

Mesoblast, Ltd.Diabetic Nephropathy, Type 2 Diabetes

Start: 2013-07-31End: 2015-09-30Updated: 2016-10-14

Phase 2

A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure

CompletedNCT00721045

Mesoblast, Ltd.Heart Failure

Start: 2008-08-31End: 2013-07-31Updated: 2020-03-11

Related Papers

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.

2016-09-17116 citations